HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial

بواسطة Heather A. Prentice, Philip K. Ehrenberg, Karen M. Baldwin, Aviva Geretz, Charla Andrews, Sorachai Nitayaphan, Supachai Rerks-Ngarm, Jaranit Kaewkungwal, Punnee Pitisuttithum, Robert J. O'Connell, Merlin L. Robb, Jerome H. Kim, Nelson L. Michael, Rasmi Thomas
منشور في 2018